CDEK
← All organizations

Transcept Pharmaceuticals

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Apr 1, 2006

Last known activity

Jan 1, 2011

Acquired by Paratek Pharmaceuticals Inc → Novo Nordisk on Jun 1, 1996

Timeline

1990s

  1. Jun 1, 1996

    Paratek Pharmaceuticals Inc— Acquired By

2000s

  1. Jul 1, 2001

    Transcept Pharmaceuticals— Founded

  2. Feb 2, 2009

    Novacea— Acquired

2020s

  1. Sep 18, 2023

    Novo Nordisk— Now

Drugs by trial phase (10 distinct, 15 trials)

Phase 3 (1 own, 2 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (4)

Details

Founded
Richmond, CA, US Jul 1, 2001
Last known activity
Jan 1, 2011

Notes

Acquired by Paratek 30 Oct 2014